Internal Medicine, Infectious Disease · New York, NY
NPI
1669417796
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
600 West 168th Street, 3rd Floor
New York, NY, 10032
Phone (212) 368-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,181
28 services
Medicare patients, 2024
16
Average age 68
Drug cost, 2024
$1.5M
2,382 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen F Brudney was code 99213 (office e&m - established), 21 times for 14 patients. In total Karen F Brudney billed 28 services in 3 codes, and Medicare paid $1,181.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 21 | 14 | $47.16 | $990 |
By year: 2022 $729 for 31 services; 2023 $1,992 for 39 services; 2024 $1,181 for 28 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen F Brudney prescribed most often to Medicare patients was Ritonavir, with 218 prescriptions and refills. In total Karen F Brudney wrote 2,382 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ritonavir Generic | 218 | 218 | 20 | $16K |
| Rosuvastatin Calcium Generic | 183 | 185 | 18 | $808 |
| Lisinopril Generic | 171 | 177 | 16 | $321 |
| Tivicay Dolutegravir Sodium | 158 | 158 | 14 | $326K |
| Darunavir Generic | 144 | 144 | 17 | $134K |
| Metformin Hcl Generic | 121 | 131 | 13 | $150 |
| Chlorthalidone Generic | 103 | 103 | Under 11 | $773 |
| Efavirenz Generic | 95 | 95 | Under 11 | $21K |
| Prezista Darunavir | 72 | 72 | 15 | $135K |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 69 | 69 | Under 11 | $16K |
| Complera Emtricita/Rilpivirine/Tenof Df | 61 | 61 | Under 11 | $205K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 52 | 56 | Under 11 | $189K |
| Descovy Emtricitabine/Tenofov Alafenam | 48 | 48 | Under 11 | $97K |
| Pravastatin Sodium Generic | 42 | 42 | Under 11 | $121 |
| Vemlidy Tenofovir Alafenamide | 40 | 40 | Under 11 | $51K |
Brand drugs: 605 claims; generic drugs: 1,710 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Karen F Brudney were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.